Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04975555
Title Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Alabama at Birmingham
Indications

multiple myeloma

B-cell lymphoma

primary mediastinal B-cell lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

mantle cell lymphoma

B-cell acute lymphoblastic leukemia

Therapies

Siltuximab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.